Within his role as a Managing Director at ClearView Healthcare Partners, Mike assists clients in developing product and therapeutic area strategies and provides a unique perspective on global pricing, reimbursement, and market access. In addition to broad therapeutic area knowledge, Mike has expertise in characterizing the roles and impact of organized customers, including regulators, payers, distributors, hospital systems, and provider groups. He places significant importance on professional mentorship, client focus, and developing practical solutions for complex business needs.
Mike began his life-sciences career in genomics research before transitioning into healthcare policy and finally establishing himself in consulting. Over the last 10 years he has focused on addressing strategic business issues for leading pharmaceutical and biotechnology companies. Prior to joining ClearView, Mike held positions at Leerink Swann, Double Helix and Campbell Alliance.
Mike holds an MBA from the College of William and Mary and a Master of Public Policy focused on pharmaceutical pricing regulations from Georgetown University.
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
David Gilman
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Steve Rubman
Debbi Amanti Belanger
Kim Goh
Slater Hurst
Dave Konciak
Charles Mathews
Mike Rizzo
Mike Roy
Ryan Tubman
Beko Binder
Jonny Betts
Dean Griffiths
Maneesh Gujrati
Austin Hubbert
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian